Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
5.64
-0.60 (-9.62%)
At close: May 23, 2025, 4:00 PM
5.74
+0.10 (1.76%)
After-hours: May 23, 2025, 7:30 PM EDT
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $488.28 million as of May 23, 2025. Its market cap has decreased by -69.49% in one year.
Market Cap
488.28M
Enterprise Value
-148.82M
1-Year Change
-69.49%
Ranking
Category
Stock Price
$5.64
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $488.28M, an increase of 329.45%. That is a compound annual growth rate of 16.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2025 | 536.80M | -20.74% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.36B |
| Johnson & Johnson | 368.35B |
| AbbVie | 323.20B |
| Novo Nordisk | 308.07B |
| UnitedHealth Group | 271.63B |
| Abbott Laboratories | 230.11B |
| Novartis AG | 219.95B |
| AstraZeneca | 215.99B |